covid-19

Documents about covid-19

• 12 U.S.C. § 4703a — Capital investments for neighborhoods disproportionately impacted by the COVID–19 pandemic#563590US Code (LII)
• Safety and Efficacy of Intranasal Administration of Avacc 10 Vaccine Against COVID-19 in Healthy Volunteers#18695ClinicalTrials.gov
• A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age#18719ClinicalTrials.gov
• A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells)#28431ClinicalTrials.gov
• A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults#28433ClinicalTrials.gov
• Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell)#28437ClinicalTrials.gov
• Immunogenicity of an Inactivated COVID-19 Vaccine#28440ClinicalTrials.gov
• Effectiveness of Covid-19 Vaccination in Eswatini Against SARS-CoV-2 Associated Hospitalization and Death#28444ClinicalTrials.gov
• Covid-19 Patients With Hypertension and/or Kidney Diseases#28478ClinicalTrials.gov
• Message From Local Pharmacy Team#67661ClinicalTrials.gov
• Homologous vs Heterologous Third Vaccination in Kidney Transplant Recipients Kidney Transplant Recipients#67668ClinicalTrials.gov
• Non-specific Effects of FLU-MMR Vaccines in Adults#67700ClinicalTrials.gov
• A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)#121443ClinicalTrials.gov
• Phase 2a Trial to Evaluate Safety and Immunogenicity of COVID-19 Vaccine Strategies in HIV-infected/Uninfected Adults.#121449ClinicalTrials.gov
• Safety and Immunogenicity Study of EgyVax Vaccine Candidate for Prophylaxis of COVID-19 Infection#121455ClinicalTrials.gov
• Study to Evaluate the Efficacy of IN STI-9199 in Treating Symptomatic COVID-19 in Outpatient Adults and Adolescents#121461ClinicalTrials.gov
• A Clinical Trial of Immunobridging and Lot-to-lot Consistency of COVID-19 Vaccine (Ad5-nCoV) in Different Age Groups.#123537ClinicalTrials.gov
• Evaluation of the Immunogenicity and Safety of Ad26.COV2.S's COVID-19 Vaccine#123540ClinicalTrials.gov
• Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and Adolescents#123547ClinicalTrials.gov
• A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in COVID-19 Patients With Acute Pulmonary Hypertension#123581ClinicalTrials.gov
• THE IMPORTANCE OF FORCE MAJEURE IN VARIOUS JURISDICTIONS AND ITS CONTEMPORARY CHALLENGES#124182Zenodo (CERN)
• Potential of regulatory T cell-based therapies in the management of severe COVID-19#7997HAL (France)
• Effect of COVID-19 pandemic on ART access and timely initiation in people living with HIV in 31 countries: a regression discontinuity design study#15503HAL (France)
• Biomarkers and early-onset acute kidney injury in critically ill COVID-19 patients, a prospective monocentric observational study#124405HAL (France)
• Etude de l’hétérogénéité clinique, de la variabilité virale et de la réponse immunitaire au cours des pneumonies virales graves#124493HAL (France)
• Bleeding Hazard of Percutaneous Tracheostomy in COVID-19 Patients Supported With Venovenous Extracorporeal Membrane Oxygenation: A Case Series#200336Figshare
• Table 1_CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccine.docx#202136Figshare

Related topics